Stocks and Investing
Stocks and Investing
Wed, November 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (SLRN) at Hold with Decreased Target to $13 on, Nov 29th, 2023
Vikram Purohit of Morgan Stanley, Maintained "Acelyrin, Inc." (SLRN) at Hold with Decreased Target from $19 to $13 on, Nov 29th, 2023.
Vikram has made no other calls on SLRN in the last 4 months.
There are 2 other peers that have a rating on SLRN. Out of the 2 peers that are also analyzing SLRN, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Vikram
- Akash Tewari of "Jefferies" Maintained at Strong Buy with Decreased Target to $12 on, Tuesday, November 28th, 2023
- Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Tuesday, November 28th, 2023
Contributing Sources